Search research articles
Contact Us
Filters
Showing results (781-790 of 1,350) with videos related to
Page
of 135
Sort By:
Drug Development Research
|
June 16, 2025
Clinical Investigation of Tyrosinase Inhibitors: Past, Present, and Future
Yuanyuan Wang, Ruijia Jiang, Baichen Xiong, et al.
Drug Development Research
|
July 10, 2025
TRPC1 and TRPC5 in Colorectal Cancer: Mechanisms, Prognostic Markers, and Therapeutic Targets
Manal A Abbas, Aya Y Al-Kabariti, Randa El-Rayyes, et al.
Drug Development Research
|
June 19, 2025
Design, Synthesis, and Biological Evaluation of Potent FLT3 Inhibitor for Acute Myeloid Leukemia (AML) Treatment
Kun Du, Yanan He, Jinyang Fu, et al.
Drug Development Research
|
October 5, 2025
Targeting mTOR Kinase for Cancer Treatment: A Comprehensive Review With Clinical Insights
Md Takdir Hossain, Md Arafat Hossain
Drug Development Research
|
September 26, 2025
Oleuropein Modulates Mitophagy and Metabolism in Cardiomyocyte Via the PINK1/Parkin Signaling Pathway
Hao Ling, Chunli Song
Drug Development Research
|
September 30, 2025
Rational Discovery of BACE1-Selective Inhibitors as Potential Therapeutics for Alzheimer's Disease
Tanmaykumar Varma, Pradnya Kamble, Prabha Garg
Drug Development Research
|
September 26, 2025
Neuroprotective Effects of Liraglutide and/or Rivastigmine Combination on the Rat Hippocampus
Raafat A Abdel-Aal, Mohammad Salem Hareedy, Dalia M Badary, et al.
Drug Development Research
|
December 18, 2025
Next-Generation Therapies for Bone Cancer: Targeted Therapy, Immunotherapy, and Nanomedicine Innovations
Kun Wang, Epiphane K Silli, Huixia Lv, et al.
Drug Development Research
|
December 15, 2025
Potent Therapeutic Efficacy of 9-Bromo-Noscapine Against Breast Cancer Cells Via Enhanced Bioavailability of the Noscapine-Cyclodextrin Inclusion Complex
Namita Bhoi, Lilesh Kumar Pradhan, Dibya Ranjan Sahoo, et al.
Drug Development Research
|
April 7, 2025
HIF-Prolyl Hydroxylase Inhibitor Desidustat Increases Pyruvate Kinase Activity and Reduces Oxidative Stress in Red Blood Cells, Causes Erythrocytosis in Thalassaemic Mice, and Reduces Sickling in Sickle Cell Patient's Blood
Vishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Page
of 135
Search research articles
Search
Showing results (781-790 of 1,350) with videos related to
Sort By:
Page
of 135
Drug Development Research
|
June 16, 2025
Clinical Investigation of Tyrosinase Inhibitors: Past, Present, and Future
Yuanyuan Wang, Ruijia Jiang, Baichen Xiong, et al.
Drug Development Research
|
July 10, 2025
TRPC1 and TRPC5 in Colorectal Cancer: Mechanisms, Prognostic Markers, and Therapeutic Targets
Manal A Abbas, Aya Y Al-Kabariti, Randa El-Rayyes, et al.
Drug Development Research
|
June 19, 2025
Design, Synthesis, and Biological Evaluation of Potent FLT3 Inhibitor for Acute Myeloid Leukemia (AML) Treatment
Kun Du, Yanan He, Jinyang Fu, et al.
Drug Development Research
|
October 5, 2025
Targeting mTOR Kinase for Cancer Treatment: A Comprehensive Review With Clinical Insights
Md Takdir Hossain, Md Arafat Hossain
Drug Development Research
|
September 26, 2025
Oleuropein Modulates Mitophagy and Metabolism in Cardiomyocyte Via the PINK1/Parkin Signaling Pathway
Hao Ling, Chunli Song
Drug Development Research
|
September 30, 2025
Rational Discovery of BACE1-Selective Inhibitors as Potential Therapeutics for Alzheimer's Disease
Tanmaykumar Varma, Pradnya Kamble, Prabha Garg
Drug Development Research
|
September 26, 2025
Neuroprotective Effects of Liraglutide and/or Rivastigmine Combination on the Rat Hippocampus
Raafat A Abdel-Aal, Mohammad Salem Hareedy, Dalia M Badary, et al.
Drug Development Research
|
December 18, 2025
Next-Generation Therapies for Bone Cancer: Targeted Therapy, Immunotherapy, and Nanomedicine Innovations
Kun Wang, Epiphane K Silli, Huixia Lv, et al.
Drug Development Research
|
December 15, 2025
Potent Therapeutic Efficacy of 9-Bromo-Noscapine Against Breast Cancer Cells Via Enhanced Bioavailability of the Noscapine-Cyclodextrin Inclusion Complex
Namita Bhoi, Lilesh Kumar Pradhan, Dibya Ranjan Sahoo, et al.
Drug Development Research
|
April 7, 2025
HIF-Prolyl Hydroxylase Inhibitor Desidustat Increases Pyruvate Kinase Activity and Reduces Oxidative Stress in Red Blood Cells, Causes Erythrocytosis in Thalassaemic Mice, and Reduces Sickling in Sickle Cell Patient's Blood
Vishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Page
of 135